2022 ET Bell Fall Symposium and MSP Fall Seminar Evaluation Your opinion is vital! Please take the time to complete this evaluation in its entirety. Question Title * 1. Did this program achieve its primary objectives to change competence, performance and/or patient outcome? Yes No N/A Appropriately recognize and classify major types of salivary gland neoplasms based of characteristic morphologic features and confirmatory ancillary testing. Appropriately recognize and classify major types of salivary gland neoplasms based of characteristic morphologic features and confirmatory ancillary testing. Yes Appropriately recognize and classify major types of salivary gland neoplasms based of characteristic morphologic features and confirmatory ancillary testing. No Appropriately recognize and classify major types of salivary gland neoplasms based of characteristic morphologic features and confirmatory ancillary testing. N/A Understand and apply the most recent changes in the 2022 WHO classification system for endocrine and neuroendocrine tumors. Understand and apply the most recent changes in the 2022 WHO classification system for endocrine and neuroendocrine tumors. Yes Understand and apply the most recent changes in the 2022 WHO classification system for endocrine and neuroendocrine tumors. No Understand and apply the most recent changes in the 2022 WHO classification system for endocrine and neuroendocrine tumors. N/A Recognize the histologic patterns, differentiate, and classify thymic neoplasms in accordance with current guidelines. Recognize the histologic patterns, differentiate, and classify thymic neoplasms in accordance with current guidelines. Yes Recognize the histologic patterns, differentiate, and classify thymic neoplasms in accordance with current guidelines. No Recognize the histologic patterns, differentiate, and classify thymic neoplasms in accordance with current guidelines. N/A Differentiate pleural neoplasms based on morphologic features and ancillary testing. Differentiate pleural neoplasms based on morphologic features and ancillary testing. Yes Differentiate pleural neoplasms based on morphologic features and ancillary testing. No Differentiate pleural neoplasms based on morphologic features and ancillary testing. N/A Understand and appropriately use molecular diagnostics in evaluating thoracic pathology.Recognize and classify most common odontogenic lesions and jaw tumors. Understand and appropriately use molecular diagnostics in evaluating thoracic pathology.Recognize and classify most common odontogenic lesions and jaw tumors. Yes Understand and appropriately use molecular diagnostics in evaluating thoracic pathology.Recognize and classify most common odontogenic lesions and jaw tumors. No Understand and appropriately use molecular diagnostics in evaluating thoracic pathology.Recognize and classify most common odontogenic lesions and jaw tumors. N/A Provide the correct diagnosis of most important interstitial lung diseases through recognition of characteristic histologic components and associated radiologic features. Provide the correct diagnosis of most important interstitial lung diseases through recognition of characteristic histologic components and associated radiologic features. Yes Provide the correct diagnosis of most important interstitial lung diseases through recognition of characteristic histologic components and associated radiologic features. No Provide the correct diagnosis of most important interstitial lung diseases through recognition of characteristic histologic components and associated radiologic features. N/A Question Title * 2. As a result of participating in this activity, the primary thing I would do differently at my practice is: Question Title * 3. What might impede you from making changes? Question Title * 4. What tools, education or advocacy would help you address this/these barriers or others you encounter in your practice setting? Question Title * 5. What practice areas could you use additional training in to practice more effectively? Question Title * 6. Was the activity free of commercial bias? Yes No If no, please explain Question Title * 7. Content pertained to my practice 5: Strongly Agree 4: Agree 3: No Opinion 2: Disagree 1: Strongly Disagree N/A Justine A. Barletta, MD Justine A. Barletta, MD 5: Strongly Agree Justine A. Barletta, MD 4: Agree Justine A. Barletta, MD 3: No Opinion Justine A. Barletta, MD 2: Disagree Justine A. Barletta, MD 1: Strongly Disagree Justine A. Barletta, MD N/A David Schembri-Wismayer, MD David Schembri-Wismayer, MD 5: Strongly Agree David Schembri-Wismayer, MD 4: Agree David Schembri-Wismayer, MD 3: No Opinion David Schembri-Wismayer, MD 2: Disagree David Schembri-Wismayer, MD 1: Strongly Disagree David Schembri-Wismayer, MD N/A Anja C. Roden, MD Anja C. Roden, MD 5: Strongly Agree Anja C. Roden, MD 4: Agree Anja C. Roden, MD 3: No Opinion Anja C. Roden, MD 2: Disagree Anja C. Roden, MD 1: Strongly Disagree Anja C. Roden, MD N/A Diana Omaras, MD Diana Omaras, MD 5: Strongly Agree Diana Omaras, MD 4: Agree Diana Omaras, MD 3: No Opinion Diana Omaras, MD 2: Disagree Diana Omaras, MD 1: Strongly Disagree Diana Omaras, MD N/A Lynette M. Sholl, MD Lynette M. Sholl, MD 5: Strongly Agree Lynette M. Sholl, MD 4: Agree Lynette M. Sholl, MD 3: No Opinion Lynette M. Sholl, MD 2: Disagree Lynette M. Sholl, MD 1: Strongly Disagree Lynette M. Sholl, MD N/A Jeffrey Myers, MD Jeffrey Myers, MD 5: Strongly Agree Jeffrey Myers, MD 4: Agree Jeffrey Myers, MD 3: No Opinion Jeffrey Myers, MD 2: Disagree Jeffrey Myers, MD 1: Strongly Disagree Jeffrey Myers, MD N/A Ioannis Koutlas, MD Ioannis Koutlas, MD 5: Strongly Agree Ioannis Koutlas, MD 4: Agree Ioannis Koutlas, MD 3: No Opinion Ioannis Koutlas, MD 2: Disagree Ioannis Koutlas, MD 1: Strongly Disagree Ioannis Koutlas, MD N/A Emil Racila, MD Emil Racila, MD 5: Strongly Agree Emil Racila, MD 4: Agree Emil Racila, MD 3: No Opinion Emil Racila, MD 2: Disagree Emil Racila, MD 1: Strongly Disagree Emil Racila, MD N/A Comments: Question Title * 8. Content provided practical approaches to implementation. 5: Strongly Agree 4: Agree 3: No Opinion 2: Disagree 1: Strongly Disagree N/A Justine A. Barletta, MD Justine A. Barletta, MD 5: Strongly Agree Justine A. Barletta, MD 4: Agree Justine A. Barletta, MD 3: No Opinion Justine A. Barletta, MD 2: Disagree Justine A. Barletta, MD 1: Strongly Disagree Justine A. Barletta, MD N/A Vickie Y. Jo, MD Vickie Y. Jo, MD 5: Strongly Agree Vickie Y. Jo, MD 4: Agree Vickie Y. Jo, MD 3: No Opinion Vickie Y. Jo, MD 2: Disagree Vickie Y. Jo, MD 1: Strongly Disagree Vickie Y. Jo, MD N/A David Schembri-Wismayer, MD David Schembri-Wismayer, MD 5: Strongly Agree David Schembri-Wismayer, MD 4: Agree David Schembri-Wismayer, MD 3: No Opinion David Schembri-Wismayer, MD 2: Disagree David Schembri-Wismayer, MD 1: Strongly Disagree David Schembri-Wismayer, MD N/A Anja C. Roden, MD Anja C. Roden, MD 5: Strongly Agree Anja C. Roden, MD 4: Agree Anja C. Roden, MD 3: No Opinion Anja C. Roden, MD 2: Disagree Anja C. Roden, MD 1: Strongly Disagree Anja C. Roden, MD N/A Diana Omaras, MD Diana Omaras, MD 5: Strongly Agree Diana Omaras, MD 4: Agree Diana Omaras, MD 3: No Opinion Diana Omaras, MD 2: Disagree Diana Omaras, MD 1: Strongly Disagree Diana Omaras, MD N/A Lynette M. Sholl, MD Lynette M. Sholl, MD 5: Strongly Agree Lynette M. Sholl, MD 4: Agree Lynette M. Sholl, MD 3: No Opinion Lynette M. Sholl, MD 2: Disagree Lynette M. Sholl, MD 1: Strongly Disagree Lynette M. Sholl, MD N/A Jeffrey Myers, MD Jeffrey Myers, MD 5: Strongly Agree Jeffrey Myers, MD 4: Agree Jeffrey Myers, MD 3: No Opinion Jeffrey Myers, MD 2: Disagree Jeffrey Myers, MD 1: Strongly Disagree Jeffrey Myers, MD N/A Ioannis Koutlas, MD Ioannis Koutlas, MD 5: Strongly Agree Ioannis Koutlas, MD 4: Agree Ioannis Koutlas, MD 3: No Opinion Ioannis Koutlas, MD 2: Disagree Ioannis Koutlas, MD 1: Strongly Disagree Ioannis Koutlas, MD N/A Emil Racila, MD Emil Racila, MD 5: Strongly Agree Emil Racila, MD 4: Agree Emil Racila, MD 3: No Opinion Emil Racila, MD 2: Disagree Emil Racila, MD 1: Strongly Disagree Emil Racila, MD N/A Comments: Question Title * 9. Additional Comments: Question Title * 10. PHYSICIAN ATTENDANCE VERIFICATION: To obtain CME credit, physicians need to complete (this serves as your signature). Name: Email Address: Question Title * 11. I claim _______ AMA PRA Category 1 credit(s)™ for participating as a learner in this activity (1 credit for each hour of participation, not to exceed 9.0 credit(s). Done